To examine whether estrogen-stimulated ER signaling contributes to the up-regulation of FASN expression in ER+ breast cancer cells, we tested whether exogenous supplementation with physiological concentrations of estradiol, a biologically active estrogen, either increased the number of cells expressing FASN and/or increased the levels of FASN expression in individual cells. Here, FASN is linked to breast cancer.